Format

Send to

Choose Destination
Rev Med Chil. 2010 Jun;138(6):752-7.

[Four-week Levitronix Centrimag bridge-to-transplant for post myocardial infarction cardiogenic shock. A case report].

[Article in Spanish]

Author information

1
Programa de Trasplante Cardiopulmonar y Soporte Cardiorrespiratorio Artificial, Departamento de Enfermedades Cardiovasculares/Respiratorias, Clínica Dávila, Santiago, Chile. villavicencio.mauricio@gmail.com

Abstract

Cardiogenic shock after myocardial infarction has a high mortality even if early revascularization is achieved. Biventricular assist devices have not been used in Chile in this critical setting. We report a case of a 55-year-old diabetic man who suffered an acute chest pain and ventricular fibrillation. Prompt outside hospital defibrillation/reanimation restored pulse and allowed emergency room transfer on mechanical ventilation. Electrocardiogram showed an anterior myocardial infarction and early revascularization was achieved by anterior descending artery angioplasty. However, severe cardiogenic shock continued in spite of inotropic and intra aortic balloon pump support. Levitronix Centrimag biventricular mechanical circulatory support was inserted during reanimation for recurrent ventricular fibrillation and the patient listed for urgent cardiac transplantation upon stabilization. Heart transplantation was performed successfully 28 days later and the patient was discharged after a 21-day recovery period. Twelve months after transplant the patient is in NYHA functional class I with normal biventricular function. Levitronix Centrimag biventricular mechanical circulatory support could be used successfully as a bridge-to-transplant for myocardial infarction cardiogenic shock.

PMID:
20919487
DOI:
10.4067/s0034-98872010000600014
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center